PropThink: Mark the Calendar; Celsion to Release ThermoDox Trial Results in January

[ACN Newswire] – By Jake KingOncology-focused Celsion Corp. (NASDAQ:CLSN) announced Friday morning that the Phase III HEAT trial met its unblinding milestone, and top-line data will be released in January of 2013, sending … more

View todays social media effects on ZIOP

View the latest stocks trending across Twitter. Click to view dashboard